Terms: = Endocrine gland cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088
14 results:
1. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract] [Full Text] [Related]
2. Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma.
Thompson CM; Cannon A; West S; Ghersi D; Atri P; Bhatia R; Smith L; Rachagani S; Wichman C; Kumar S; Batra SK
Clin Cancer Res; 2021 Dec; 27(24):6787-6799. PubMed ID: 34615717
[TBL] [Abstract] [Full Text] [Related]
3. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic cancer.
Zhou Q; Chen X; Chen Q; Liu H; Hao L
Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
[TBL] [Abstract] [Full Text] [Related]
4. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network.
Qian X; Chen Z; Chen SS; Liu LM; Zhang AQ
J Immunol Res; 2020; 2020():7503605. PubMed ID: 32537471
[TBL] [Abstract] [Full Text] [Related]
5. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome.
Bucher-Johannessen C; Page CM; Haugen TB; Wojewodzic MW; Fosså SD; Grotmol T; Haugnes HS; Rounge TB
Clin Epigenetics; 2019 Dec; 11(1):179. PubMed ID: 31796056
[TBL] [Abstract] [Full Text] [Related]
6. ptk6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic cancer.
Ono H; Basson MD; Ito H
Mol Cancer Res; 2015 Aug; 13(8):1174-84. PubMed ID: 26013168
[TBL] [Abstract] [Full Text] [Related]
7. Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/ptk6/ERK1/2 pathway.
Zhao S; Li J
PLoS One; 2015; 10(3):e0119148. PubMed ID: 25748447
[TBL] [Abstract] [Full Text] [Related]
8. ptk6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.
Ono H; Basson MD; Ito H
PLoS One; 2014; 9(5):e96060. PubMed ID: 24788754
[TBL] [Abstract] [Full Text] [Related]
9. ptk6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract] [Full Text] [Related]
10. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase brk/ptk6 in ovarian cancer cells.
Fan G; Lin G; Lucito R; Tonks NK
J Biol Chem; 2013 Aug; 288(34):24923-34. PubMed ID: 23814047
[TBL] [Abstract] [Full Text] [Related]
11. Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.
Cho NL; Lin CI; Du J; Whang EE; Ito H; Moore FD; Ruan DT
Biochem Biophys Res Commun; 2012 May; 421(3):508-13. PubMed ID: 22521882
[TBL] [Abstract] [Full Text] [Related]
12. Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.
Yu W; Jin C; Lou X; Han X; Li L; He Y; Zhang H; Ma K; Zhu J; Cheng L; Lin B
PLoS One; 2011; 6(12):e29450. PubMed ID: 22216282
[TBL] [Abstract] [Full Text] [Related]
13. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
[TBL] [Abstract] [Full Text] [Related]
14. The brk tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Schmandt RE; Bennett M; Clifford S; Thornton A; Jiang F; Broaddus RR; Sun CC; Lu KH; Sood AK; Gershenson DM
Cancer Biol Ther; 2006 Sep; 5(9):1136-41. PubMed ID: 16855388
[TBL] [Abstract] [Full Text] [Related]